Document is current
Any future updates will be listed below
-
Authors
Natarajan, Aswin
Velmurugu, Yogambigai https://orcid.org/0000-0001-6418-1048
Becerra Flores, Manuel
Dibba, Fatoumatta
Beesam, Saikiran https://orcid.org/0009-0000-6987-6236
Kikvadze, Sally https://orcid.org/0009-0002-5751-6959
Wang, Xiaotian https://orcid.org/0009-0002-3330-3975
Wang, Wenjuan
Li, Tianqi
Shin, Hye Won
Cardozo, Timothy
Krogsgaard, Michelle https://orcid.org/0000-0001-5006-7981
-
Funding
Funding for this research was provided by:
Foundation for the National Institutes of Health (NCI R21 CA263378)
Foundation for the National Institutes of Health (NIGMS R01 GM124489)
Foundation for the National Institutes of Health (NCI R01 CA284604)
Foundation for the National Institutes of Health (NCI R01 CA243486)
Foundation for the National Institutes of Health (NCI P30CA016087)
- License Information
-
More Information
Article History
Received: 30 December 2023
Revised: 22 October 2024
Accepted: 26 October 2024
First Online: 7 November 2024
Disclosure and competing interests statement
: AN declares no competing interests. MK serves on the scientific advisory boards of Genentech and Merck and Co. and received research support from Merck Sharp & Dohme Corp., a subsidiary of Merck and Co., Inc., Genentech, Biogen, Novartis and the Mark Foundation.
